ANDA 88328, held by Hospira. Lidocaine Hydrochloride.
As of Nov 16, 2026, ANDA 88328 (Lidocaine Hydrochloride), held by Hospira, was first approved by FDA on May 17, 1984, with 9 approved supplements and 0 published complete response letters.
Lidocaine Hydrochloride Injection is indicated in adult and pediatric patients for the production of local or regional anesthesia or analgesia for surgery, dental, and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. Specific concentrations and presentations of Lidocaine Hydrochloride Injection are recommended for each type of block indicated to produce local or regional anesthesia or analgesia. Lidocaine Hydrochloride Injection contains lidocaine, an amide local anesthetic.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 17, 1984 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Lidocaine Hydrochloride0.5% · injectable;injection | Lidocaine Hydrochloride | Rx |
| Mar 19, 2020 | Supplement 29Labeling · Standard review | Approved | None posted |
| Mar 19, 2020 | Supplement 30Labeling · Standard review | Approved | None posted |
| Apr 16, 2010 | Supplement 17Labeling | Approved | None posted |
| Oct 22, 1996 | Supplement 7Manufacturing | Approved | None posted |
| Oct 3, 1996 | Supplement 8Manufacturing | Approved | None posted |
| Oct 10, 1990 | Supplement 4Labeling | Approved | None posted |
| Dec 12, 1988 | Supplement 3Labeling | Approved | None posted |
| Aug 15, 1986 | Supplement 2Manufacturing | Approved | None posted |
| Apr 18, 1985 | Supplement 1Manufacturing | Approved | None posted |
| May 17, 1984 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters